Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT

Angelique V. M. Brands-Nijenhuis; Myriam Labopin; H.C. Schouten; Liisa Volin; Gerard Socie; Jan J. Cornelissen; Anne Huynh; Per Ljungman; Florent Malard; Jordi Esteve; Arnon Nagler; Mohamad Mohty

doi:10.3324/haematol.2015.132654

Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT

Angelique V. M. Brands-Nijenhuis, Myriam Labopin, H.C. Schouten, Liisa Volin, Gerard Socie, Jan J. Cornelissen, Anne Huynh, Per Ljungman, Florent Malard, Jordi Esteve, Arnon Nagler, Mohamad Mohty^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Despite the overall benefit from allogeneic hematopoietic stem cell transplantation observed in patients with poor cytogenetic risk acute myeloid leukemia in first complete remission, the precise effect of this procedure for different poor-risk subtypes has not been fully analyzed. This retrospective analysis was performed to investigate whether allogeneic hematopoietic stem cell transplantation performed in first complete remission in patients with monosomal karyotype can overcome the adverse prognosis associated with these patients. Of the 4635 patients included in the study, 189 (4%) harbored a monosomal karyotype. The presence of a monosomal karyotype was associated with a worse outcome, with an inferior leukemia-free survival and overall survival (5-year leukemia-free survival and overall survival: 24 +/- 3% and 26 +/- 3% vs. 53 +/- 1% and 57 +/- 1% in monosomal-karyotype and non-monosomal-karyotype, respectively; P

Original language	English
Pages (from-to)	248-255
Journal	Haematologica-the Hematology Journal
Volume	101
Issue number	2
DOIs	https://doi.org/10.3324/haematol.2015.132654
Publication status	Published - Feb 2016

Access to Document

10.3324/haematol.2015.132654Licence: CC BY-NC

Cite this

Brands-Nijenhuis, A. V. M., Labopin, M., Schouten, H. C., Volin, L., Socie, G., Cornelissen, J. J., Huynh, A., Ljungman, P., Malard, F., Esteve, J., Nagler, A., & Mohty, M. (2016). Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT. Haematologica-the Hematology Journal, 101(2), 248-255. https://doi.org/10.3324/haematol.2015.132654

Brands-Nijenhuis, Angelique V. M. ; Labopin, Myriam ; Schouten, H.C. et al. / Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT. In: Haematologica-the Hematology Journal. 2016 ; Vol. 101, No. 2. pp. 248-255.

@article{a9d773d20041419ba170c360cd0ac10f,

title = "Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT",

abstract = "Despite the overall benefit from allogeneic hematopoietic stem cell transplantation observed in patients with poor cytogenetic risk acute myeloid leukemia in first complete remission, the precise effect of this procedure for different poor-risk subtypes has not been fully analyzed. This retrospective analysis was performed to investigate whether allogeneic hematopoietic stem cell transplantation performed in first complete remission in patients with monosomal karyotype can overcome the adverse prognosis associated with these patients. Of the 4635 patients included in the study, 189 (4%) harbored a monosomal karyotype. The presence of a monosomal karyotype was associated with a worse outcome, with an inferior leukemia-free survival and overall survival (5-year leukemia-free survival and overall survival: 24 +/- 3% and 26 +/- 3% vs. 53 +/- 1% and 57 +/- 1% in monosomal-karyotype and non-monosomal-karyotype, respectively; P",

author = "Brands-Nijenhuis, {Angelique V. M.} and Myriam Labopin and H.C. Schouten and Liisa Volin and Gerard Socie and Cornelissen, {Jan J.} and Anne Huynh and Per Ljungman and Florent Malard and Jordi Esteve and Arnon Nagler and Mohamad Mohty",

year = "2016",

month = feb,

doi = "10.3324/haematol.2015.132654",

language = "English",

volume = "101",

pages = "248--255",

journal = "Haematologica-the Hematology Journal",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "2",

}

Brands-Nijenhuis, AVM, Labopin, M, Schouten, HC, Volin, L, Socie, G, Cornelissen, JJ, Huynh, A, Ljungman, P, Malard, F, Esteve, J, Nagler, A & Mohty, M 2016, 'Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT', Haematologica-the Hematology Journal, vol. 101, no. 2, pp. 248-255. https://doi.org/10.3324/haematol.2015.132654

Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT. / Brands-Nijenhuis, Angelique V. M.; Labopin, Myriam; Schouten, H.C. et al.
In: Haematologica-the Hematology Journal, Vol. 101, No. 2, 02.2016, p. 248-255.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT

AU - Brands-Nijenhuis, Angelique V. M.

AU - Labopin, Myriam

AU - Schouten, H.C.

AU - Volin, Liisa

AU - Socie, Gerard

AU - Cornelissen, Jan J.

AU - Huynh, Anne

AU - Ljungman, Per

AU - Malard, Florent

AU - Esteve, Jordi

AU - Nagler, Arnon

AU - Mohty, Mohamad

PY - 2016/2

Y1 - 2016/2

N2 - Despite the overall benefit from allogeneic hematopoietic stem cell transplantation observed in patients with poor cytogenetic risk acute myeloid leukemia in first complete remission, the precise effect of this procedure for different poor-risk subtypes has not been fully analyzed. This retrospective analysis was performed to investigate whether allogeneic hematopoietic stem cell transplantation performed in first complete remission in patients with monosomal karyotype can overcome the adverse prognosis associated with these patients. Of the 4635 patients included in the study, 189 (4%) harbored a monosomal karyotype. The presence of a monosomal karyotype was associated with a worse outcome, with an inferior leukemia-free survival and overall survival (5-year leukemia-free survival and overall survival: 24 +/- 3% and 26 +/- 3% vs. 53 +/- 1% and 57 +/- 1% in monosomal-karyotype and non-monosomal-karyotype, respectively; P

AB - Despite the overall benefit from allogeneic hematopoietic stem cell transplantation observed in patients with poor cytogenetic risk acute myeloid leukemia in first complete remission, the precise effect of this procedure for different poor-risk subtypes has not been fully analyzed. This retrospective analysis was performed to investigate whether allogeneic hematopoietic stem cell transplantation performed in first complete remission in patients with monosomal karyotype can overcome the adverse prognosis associated with these patients. Of the 4635 patients included in the study, 189 (4%) harbored a monosomal karyotype. The presence of a monosomal karyotype was associated with a worse outcome, with an inferior leukemia-free survival and overall survival (5-year leukemia-free survival and overall survival: 24 +/- 3% and 26 +/- 3% vs. 53 +/- 1% and 57 +/- 1% in monosomal-karyotype and non-monosomal-karyotype, respectively; P

U2 - 10.3324/haematol.2015.132654

DO - 10.3324/haematol.2015.132654

M3 - Article

C2 - 26589909

SN - 0390-6078

VL - 101

SP - 248

EP - 255

JO - Haematologica-the Hematology Journal

JF - Haematologica-the Hematology Journal

IS - 2

ER -

Brands-Nijenhuis AVM, Labopin M, Schouten HC, Volin L, Socie G, Cornelissen JJ et al. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT. Haematologica-the Hematology Journal. 2016 Feb;101(2):248-255. doi: 10.3324/haematol.2015.132654